# Dingxin Capital

> Dingxin Capital is a VC fund in Shenzhen backing Manufacturing and Medical. See 47 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Shenzhen, China
- Total investments: 47
- Last investment: Aug 2026
- Lead investor: 17%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/dingxin/
- Website: http://dingxin-capital.com/index.html

Dingxin Capital is an investment management agency that specializes in equity investments. The partners are mainly from domestic first-line investment institutions such as CDH, Jiuding and Zhongjin. They have deep accumulation and rich experience in the equity investment field, paying attention to the construction of the whole organization andtrying to build a truly sustainable competition. Investment institutions.

## Contacts

5 contacts available for Dingxin Capital. Shizune tracks 4 team members at Dingxin Capital. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/dingxin-capital?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Manufacturing | 13 | 28% |
| Medical | 10 | 21% |
| Semiconductor | 10 | 21% |
| Health Care | 7 | 15% |
| Medical Device | 7 | 15% |

47 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 11 | 23% |
| Seed | 10 | 21% |
| Funding Round | 7 | 15% |
| Series B | 5 | 11% |
| Venture - Series Unknown | 5 | 11% |

8 stages tracked in total.

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Deng Ning | Partner | 4 | https://shizune.co/investors/profile/deng-ning-5672 |
| Hu Hui | Founding partner | 2 | https://shizune.co/investors/profile/hu-hui-c320 |
| Yu Kang | Senior Investment Manager | 0 | https://shizune.co/investors/profile/yu-kang |
| Zhou Zhou | Senior Partner | 1 | https://shizune.co/investors/profile/zhou-zhou-522c |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Light Year Exploration | Light Year Exploration is a distributor of vehicle mechanical products. |  | Seed | Aug 03, 2026 |  |
| Xingyuan Zongheng Network Technology | Beijing Xingyuan Zongheng Network Technology is an aerospace and satellite internet enterprise. The company focuses on high-tech satellite system development, constellation networking, and commercial operations. | $14.8M | Angel | Jul 17, 2026 |  |
| Xingaotopi | Xingaotopi focuses on the innovative development of novel therapeutic drugs for sensorineural hearing loss, aiming to restore auditory function and improve quality of life through advanced biomedical research and cutting-edge treatment technologies. | $14.3M | Seed | Jan 04, 2026 |  |
| Novlead Biotech | Novlead Biotech contributes to a safer and healthier human well-being through our technological innovations. |  | Series C | Apr 15, 2025 |  |
| Fine Vision | Fine Vision is a company with R&D facilities in Nanjing and Wuhan that focuses on femtosecond laser application research in the fields of ocular surgery and biomaterial processing. The entire femtosecond laser corneal refractive surgery equipment, its first commercially available item, was developed by the university's WuhanOptoelectronics National Research Center under the Huazhong Technology Technology transition. |  | Series A | Jan 16, 2025 |  |
| Jike Optoelectronics | Jike Optoelectronics is an R&D and production firm for optical components, and they employ a special micro-nano processing technique to make side surface waveguides incredibly smooth. | $13.8M | Series A | Jun 26, 2024 |  |
| Zhihe Biotechnology | Zhihe Bio is a synthetic biology manufacturer of oleochemicals. | $1.4M | Seed | May 20, 2024 |  |
| Reju Therapeutics | Reju Therapeutics, a biopharmaceutical company, is dedicated to research and development of drugs for treating degenerative diseases like neurodegenerative, fibrotic, and inflammatory conditions. |  | Seed | May 08, 2024 |  |
| Ruining Bio | Ruining Bio provides clinical medical solutions such as tumor radiotherapy protection, wound repair, tumor embolization, and anti-tumor drugs. Ruining Bio brings together various professionals in materials, chemistry, biomedical engineering, and clinical medicine. | $8.5M | Series B | Jan 24, 2024 |  |
| Legendsemi | Legendsemi focuses on the development and design of high-performance analog and mixed-signal chips. | $13.9M | Series A | Jun 21, 2023 |  |

10 of 47 investments shown.

## Co-investors
- [Prox Ventures](https://shizune.co/investors/profile/prox-ventures) — VC Fund, 3 deals together
- [CAS Star](https://shizune.co/investors/profile/cas-star) — VC Fund, 2 deals together
- [Grit Ventures](https://shizune.co/investors/profile/grit-ventures-7f8a) — VC Fund, 2 deals together
- [Lilly Asia Ventures](https://shizune.co/investors/profile/lilly-asia-ventures) — VC Fund, 2 deals together
- [Longpan Investment](https://shizune.co/investors/profile/longpan-investment) — VC Fund, 2 deals together
- [Nanjing Innovation Capital Group](https://shizune.co/investors/profile/nanjing-innovation-capital-group) — VC Fund, 2 deals together

## Similar investors

### Similar industry
- [Innova Memphis](https://shizune.co/investors/profile/innova-memphis) — VC Fund
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [Enterprise Ireland](https://shizune.co/investors/profile/enterprise-ireland) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

### Similar country
- [IDG Capital](https://shizune.co/investors/profile/idg-capital-partners) — VC Fund
- [Qiming Venture Partners](https://shizune.co/investors/profile/qiming-venture-partners) — VC Fund
- [HSG](https://shizune.co/investors/profile/sequoia-capital-china) — VC Fund

## Featured in investor lists
- [Medical Device VC Funds in China](https://shizune.co/investors/medical-device-vc-funds-china)

## FAQ

### What does Dingxin Capital invest in?

Dingxin Capital invests primarily in Manufacturing, Medical and Semiconductor startups, most often at Series A and Seed stage. Most of the 47 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Dingxin Capital?

Public channels for Dingxin Capital include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Dingxin Capital?

The team at Dingxin Capital includes Deng Ning (Partner), Hu Hui (Founding partner) and Yu Kang (Senior Investment Manager). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co